Prevalence and Treatment of Anal Incontinence (AI) in Primiparous Women
24 de agosto de 2016 actualizado por: Ostfold Hospital Trust
Prevalence and Treatment of Anal Incontinence in Primiparous Women
Traumatic tears of the sphincter ani muscles after delivery may result in symptomatic urinary and anal incontinence, particularly in primiparas.
The efficacy of pelvic floor muscle exercise (PFME) in treating urinary incontinence (UI)is well documented, however, to date there is little evidence to support the efficacy of PFME in treating symptomatic anal incontinence.
This project consists of three separate studies. The prevalence survey/ study (1), investigates the prevalence of symptomatic anal incontinence among primiparas at Ostfold Hospital Trust Fredrikstad, Norway and St Olav's Hospital, Trondheim University Hospital, Norway, and the results in this study will form the basis of the two identical randomized controlled trials (RCT) investigating the treatment efficacy of PFME two groups of postpartum women. Women reporting symptomatic anal incontinence at six months postpartum (2) and women who have sustained a traumatic 3rd or 4th degree tear of the sphincter ani muscles during delivery (3), respectively, are randomized to an intervention group receiving PFME treatment for six months, or a control group. All RCT participants will undergo examination of PFM strength and activity, as well as anal ultrasound prior to randomization and after the intervention period.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Descripción detallada
The recruitment in RCT ( 2) has been lower than expected (49/72).
Due to financial reasons and problems with logistics and preparations for the main hospital (Ostfold Hospital Trust) moving into a new hospital, we were unable to extend the recruitment period in study 1.
In RCT (3) AI was not an inclusion criterion.
However, as both RCTs had the same outcome measure; anal incontinence, and a joint randomization process, stratified on hospital site and whether the participants had sustained an obsteric anal sphincter injury at delivery or not, the results from these studies will be reported together.
Tipo de estudio
Intervencionista
Inscripción (Actual)
1718
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
Ostfold
-
Sarpsborg, Ostfold, Noruega, 1714
- Ostfold Hospital Trust
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años y mayores (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Femenino
Descripción
Inclusion Criteria:
- primiparas aged 18 years or over with adequate knowledge of the Norwegian Language (prevalence study)
- Primiparas (Prevalence study and RCT 2)
- Women with obstetric anal sphincter injury with primary repair at delivery (RCT 3)
Exclusion Criteria all studies:
- Inadequate knowledge of the Norwegian language
- Diabetes mellitus
- Irritable bowel syndrome
- Neurological diseases such as Multiple Sclerosis
- Previous abdominal/colon surgery
In RCT studies:
Women who have already started pelvic floor muscle training postpartum due to severe anal incontinence or pelvic floor dysfunction
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Control group, RCT2
Participants reporting anal incontinence 6 months postpartum receiving written information only for 6 months.
After 6 months they are offered the same intervention as the intervention group, i.e.
PFMT for 6 months.
|
|
|
Comparador activo: Intervention group, RCT 2
Participants reporting anal incontinence 6 months postpartum receiving pelvic floor muscle training (PFMT) for 6 months (+6 months).
|
6 months of daily pelvic floor exercise treatment with regular follow up by specialist physiotherapist.
|
|
Sin intervención: Control group, RCT3
Women with obsteric anal sphincter injury receiving written information only for 6 months.
After 6 months they are offered the same intervention as the intervention group, i.e.
PFMT for 6 months.
|
|
|
Comparador activo: Intervention group, RCT 3
Women with obsteric anal sphincter injury receiving pelvic floor muscle training (PFMT) for 6 months (+6 months).
|
6 months of daily pelvic floor exercise treatment with regular follow up by specialist physiotherapist.
|
|
Sin intervención: Prevalence Study
1571 primiparae delivering at Ostfold Hospital Trust or St. Olav's Hospital during the period May 2009 to December 2010.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Anal Incontinence as Measured on the St. Mark's Score
Periodo de tiempo: 0 to 24 months postpartum
|
Survey and interview using the questionnaire St. Mark's incontinence score ranging from 0 (no incontinence) -24 (complete incontinence) points for measuring anal incontinence (AI).
The A total of 1069 women responded to the questionnaires at 6 months postpartum and 1031 at 12 months postpartum.
Discrepancies in the number of included and analysed participants in the PFME trials are related to the number of women who did not attend the follow-up appointments as described in the published paper.
|
0 to 24 months postpartum
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Urinary Incontinence as Measured on ICI-Q UI SF
Periodo de tiempo: 0 to 24 months postpartum
|
International Consultation of Incontinence Questionnaire, short form (ICI-Q SF) ranges from 0 (Complete continence) to 21 (Complete incontinence) and measures the frequency of UI, amount of leakage and impact on quality of life. Data have not been analysed. |
0 to 24 months postpartum
|
|
Fecal Incontinence of Life (FIQL) Scale
Periodo de tiempo: 0 to 24 months postpartum
|
Change in health-related quality of Life as measured on the fecal incontinence quality of life scale (FIQL).
There is no total scale, only four sub scales ranging from 4 (complete continence, no impact on QoL) to 1 (complete incontinence, severe impact on QoL) Data from the postpartum period has not and will not be analysed due to low numbers.
|
0 to 24 months postpartum
|
|
Change in Pelvic Floor Muscle Function Test as Measured on the ICS Scale
Periodo de tiempo: 12 to 24 months postpartum
|
Digital palpation and grading of voluntary pelvic floor muscle contraction (1=absent, 2=weak, 3=normal, 4=strong).
|
12 to 24 months postpartum
|
|
Change in Manometry Measurements
Periodo de tiempo: 12 to 24 months postpartum
|
manometric measurements of pelvic floor muscle strength and anal sphincter length during voluntary pelvic floor muscle contraction
|
12 to 24 months postpartum
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: Arvid Stordahl, MD PhD, Ostfold Hospital Trust
Publicaciones y enlaces útiles
La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.
Publicaciones Generales
- Johannessen HH, Wibe A, Stordahl A, Sandvik L, Backe B, Morkved S. Prevalence and predictors of anal incontinence during pregnancy and 1 year after delivery: a prospective cohort study. BJOG. 2014 Feb;121(3):269-79. doi: 10.1111/1471-0528.12438. Epub 2013 Sep 10.
- Johannessen HH, Morkved S, Stordahl A, Sandvik L, Wibe A. Anal incontinence and Quality of Life in late pregnancy: a cross-sectional study. BJOG. 2014 Jul;121(8):978-87. doi: 10.1111/1471-0528.12643. Epub 2014 Mar 4.
- Johannessen HH, Wibe A, Stordahl A, Sandvik L, Morkved S. Anal incontinence among first time mothers - what happens in pregnancy and the first year after delivery? Acta Obstet Gynecol Scand. 2015 Sep;94(9):1005-13. doi: 10.1111/aogs.12689. Epub 2015 Jun 23.
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio
1 de mayo de 2009
Finalización primaria (Actual)
1 de abril de 2014
Finalización del estudio (Actual)
1 de abril de 2014
Fechas de registro del estudio
Enviado por primera vez
1 de septiembre de 2009
Primero enviado que cumplió con los criterios de control de calidad
1 de septiembre de 2009
Publicado por primera vez (Estimar)
2 de septiembre de 2009
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
18 de octubre de 2016
Última actualización enviada que cumplió con los criterios de control de calidad
24 de agosto de 2016
Última verificación
1 de agosto de 2016
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 3170 (Otro identificador: CTEP)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Incontinencia Fecal
-
University College London HospitalsDesconocidoIncontinencia Fecal | Incontinencia fecal | Incontinencia fecal con urgencia fecalReino Unido
-
InnoCon MedicalReclutamientoIncontinencia fecal | Incontinencia fecal con urgencia fecalEspaña
-
Chinese University of Hong KongHealth and Medical Research FundTerminadoNeuromodulación | Incontinencia fecal | Estimulación nerviosa eléctrica transcutánea | Incontinencia fecal con urgencia fecal | Puntos de acupunturaHong Kong
-
Mead Johnson NutritionMidwest Children's Health Research InstituteTerminado
-
University of AarhusUniversity of Tromso; Hvidovre University HospitalTerminadoIncontinencia Fecal | Incontinencia fecalDinamarca
-
Andalusian Initiative for Advanced Therapies -...Iniciativa Andaluza en Terapias AvanzadasTerminado
-
NorgineTerminadoIncontinencia fecalEspaña, Polonia, Reino Unido, República Checa, Francia, Alemania, Hungría, Italia, Suecia
-
Boston Medical CenterTerminadoPrueba inmunoquímica fecalEstados Unidos
-
Batterjee Medical CollegeBenha UniversityTerminadoIncontinencia fecal en niñosEgipto
-
The Functional Gut ClinicReclutamiento